AMENDED AND RESTATED NOTE PURCHASE AGREEMENTAmended and Restated Note Purchase Agreement • March 13th, 2009 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
THIS AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of March 10, 2009, by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the “Company”), and PYXIS INNOVATIONS INC., a Delaware corporation (“Pyxis”).
AMENDED AND RESTATED NOTE PURCHASE AGREEMENTAmended and Restated Note Purchase Agreement • April 18th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of March 31, 2017 (the “Effective Date”), by and among Napo Pharmaceuticals, Inc., a Delaware Corporation (“Napo” or the “Company”), Kingdon Associates (“Kingdon Associates”), M. Kingdon Offshore Master Fund L.P. (“Kingdon Offshore Master Fund”), Kingdon Family Partnership, L.P. (“Kingdon Family Partnership”), and Kingdon Credit Master Fund L.P. (“Kingdon Credit Master Fund” and, together with Kingdon Associates, Kingdon Offshore Master Fund, Kingdon Family Partnership and any other party purchasing Notes (as defined below) pursuant to this Agreement, collectively, the “Purchasers” and each, a “Purchaser”). This Agreement shall amend and restate that certain Note Purchase Agreement, dated December 30, 2016 (the “Original Effective Date”), by and among the Company and the Purchasers (the “Original Agreement”).
AMENDED AND RESTATED NOTE PURCHASE AGREEMENTAmended and Restated Note Purchase Agreement • July 17th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of July 16, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
AMENDED AND RESTATED NOTE PURCHASE AGREEMENTAmended and Restated Note Purchase Agreement • April 3rd, 2012 • BioDrain Medical, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This Amended and Restated Note Purchase Agreement (the “Agreement”) is made and entered into as of December 20, 2011 by and among BioDrain Medical, Inc., a Minnesota corporation (the “Company”), and Dr. Samuel Herschkowitz or his designees (the “Purchaser”).
AMENDED AND RESTATED NOTE PURCHASE AGREEMENTAmended and Restated Note Purchase Agreement • February 9th, 2022 • Boatim Inc. • Services-computer processing & data preparation • Florida
THIS AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), originally executed on January 7, 2022, (the “Execution Date”), and amended and restated on February [__], 2022 (the “Restatement Date”), is entered into by and between BOATIM, INC., a Nevada corporation (the “Company”), and QUICK CAPITAL, LLC, a Wyoming limited liability company (the “Buyer”). Each capitalized term used herein shall have the meaning ascribed thereto in Section 10 below, or as otherwise defined herein.
